Chairman of Chia Tai Tianqing：Rooted in Nanjing to Build a Large - Scale R&D and Production Base for Biomedicine”

On the morning of April 26th, the "Hong Kong Business Leaderon Nanjing-Hong Kong Cooperation" was held at the Nanjing International Conference Hotel. Xie Chengrun, Chief Executive Officer, China National Biotec Group Chairman, Chia Tai Tianqing Pharmaceutical Group， said in an interview that Nanjing has an excellent business environment and provides strong support for the biopharmaceutical industry. CTPH has always firmly regarded Nanjing as a large-scale base for the production and research of biopharmaceuticals.

Source: Nanjing Daily